Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)
Clinical trial NCT02559687 · COMPLETED
Trial details
- NCT number
- NCT02559687
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2018-07-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.